Tampa General Hospital Cancer Institute introduces AI precision surgery CyberKnife
TAMPA (BLOOM) – Tampa General Hospital (TGH) Cancer Institute has unveiled its latest tool in the fight against cancer: the CyberKnife S7, a state-of-the-art, AI-powered radiosurgery tool. This innovative device marks a significant leap forward in cancer treatment, offering non-invasive and precise therapy for patients with both benign and cancerous tumors as well as neurologic disorders.
The CyberKnife S7 is a robotic radiation therapy device equipped with real-time, AI-driven motion tracking and synchronized treatment delivery capabilities. Its introduction at the newly established Center for Precision Radiosurgery at TGH signifies a transformative approach to treating tumors and neurologic disorders, potentially reducing treatment times to as little as 15 minutes.
Dr. Richard Tuli, professor and chair of the Department of Radiation Oncology at USF Health Morsani College of Medicine, deputy director of the TGH Cancer Institute, and director of Radiation Oncology at Tampa General, emphasized the tool’s role in enhancing the institute’s capabilities. “This represents a significant advancement in providing our patients with the best possible care across the Tampa Bay region and the state,” Dr. Tuli said. He highlighted the CyberKnife S7’s robotic precision in delivering personalized therapy, especially for difficult-to-reach tumors.
Manufactured by Accuray Incorporated, the CyberKnife S7 can treat a wide range of tumors located in various parts of the body, including the prostate, lung, brain, spine, and more. It is particularly beneficial for patients with inoperable or surgically complex tumors, offering a non-surgical alternative with treatments typically completed in one to five sessions.
One of the key features of the CyberKnife S7 is its ability to adapt to patient movement during treatment, ensuring accuracy and reducing risks. Dr. Brian Collins, a professor of Radiation Oncology and director of CNS Oncology & Radiosurgery at USF Health Morsani College of Medicine, lauded the tool’s advanced technology. “Ten years ago, no one would have thought this kind of technology was possible,” he remarked.
The system’s unique robotic design enables radiation delivery from numerous angles, allowing for a highly targeted radiation dose while protecting surrounding healthy tissue. Dr. Eduardo Sotomayor, vice president and executive director of TGH Cancer Institute, expressed pride in the establishment of the Center for Precision Radiosurgery and the inclusion of the CyberKnife S7. “This highlights our commitment to highly personalized, innovative, and compassionate cancer care,” he stated.
In addition to the CyberKnife S7, the TGH Cancer Institute offers a comprehensive range of services for cancer treatment, including the TrueBeam™ system, high-dose-rate (HDR) brachytherapy, and radiopharmaceuticals. The institute is also planning a 44,000-square-foot Proton Therapy Center adjacent to downtown Tampa.
The expansion of the TGH Cancer Institute, including a satellite location at the TGH Outpatient Center in Brandon, reflects the hospital’s commitment to patient-centric services. Dr. Abraham Schwarzberg, executive vice president, chief of Oncology, and president of the Tampa General Provider Network, highlighted the importance of innovation in providing the finest treatment options. “Our enhancements in Radiation Oncology, including CyberKnife, demonstrate our dedication to bringing advanced resources directly to those in need,” he said.
For the latest news, weather, sports, and streaming video, head to WFLA.
